Q2 Outliers: 16 Stocks Beating Earnings Estimates
Although technology and AI have remained central to the growth narrative in the second-quarter earnings season, the latest data shows that this season is not just a tech earnings story.
Meiragtx Holdings Plc (MGTX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 10,786,658 | $145,727,749 | +5% | 2.19% |
| 2. | Rubric Capital Management David Rosen | 9,100,000 | $122,941,000 | +30% | 1.13% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 4,400,000 | $59,444,000 | +10% | 0.08% |
| 4. | Opaleye Management James A. Silverman | 3,550,000 | $47,960,500 | +68% | 4.34% |
| 5. | Millennium Management Israel Englander | 2,971,752 | $40,148,370 | -15% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 1,250,000 | $5,000,000.00 | 12,531,103 | 2024-08-12 | Filing | |
| $5.75 | 4,347,826 | $24,999,999.50 | 11,281,103 | 2023-05-05 | Filing | |
| $7.89 | 6 | $47.34 | 5,000 | 2022-06-03 | Filing | |
| $7.90 | 4,994 | $39,452.60 | 4,994 | 2022-06-03 | Filing | |
| $7.94 | 1,000 | $7,940.00 | 1,000 | 2022-05-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.86 | 62,000 | $859,320.00 | 1,325,695 | 2026-08-18 | Filing | |
| $12.51 | 56,000 | $700,560.00 | 908,530 | 2026-07-21 | Filing | |
| $14.90 | 25,112 | $374,168.80 | 640,846 | 2026-07-07 | Filing | |
| $13.86 | 2,547 | $35,301.42 | 665,958 | 2026-07-07 | Filing | |
| $9.17 | 62,000 | $568,540.00 | 1,387,695 | 2026-05-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,197,737 | $164,791,427 | 30.86% | |
| 2. | 6,641,064 | $89,720,775 | 11.23% | |
| 3. | 4,757,178 | $64,269,475 | 0% | |
| 4. | 1,393,222 | $18,822,429 | 0% | |
| 5. | 1,312,703 | $17,734,617 | 0% |
News See All
10 Best Gene Therapy Stocks to Buy in 2026
Gene therapies aim to treat or prevent diseases by introducing new instructions in a patient’s cells to fix or replace the defective genes behind genetic disorders.
10 Best Growth Stocks Under $10 to Invest In
On April 22, Andrew Slimmon, Morgan Stanley Investment Management senior portfolio manager, joined CNBC's 'Squawk Box' to discuss the current state of the market and its various influences.
Evercore Maintains Positive Stance on MeiraGTx Holdings plc (MGTX) Amid Sector Revisions
TheFly reported on April 1 that Evercore ISI analyst Gavin Clark-Gartner reduced the price target on MGTX from $20 to $18 while maintaining an Outperform rating.
10 Best Biotech Stocks Under $10 to Buy
According to Eli Casdin, CEO of Casdin Capital, biotech is currently experiencing a momentary stop despite being in one of the best economic environments in years.
Top 10 AI News Updates Taking Wall Street By Storm
Escalating costs for developing bigger and more powerful artificial models has always been a big problem.
Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
10 Best Rated Penny Stocks To Buy According to Analysts
Penny stocks, often defined as shares trading for less than $5, present a high-risk, high-reward investment opportunity.
Jim Cramer is Recommending These Stocks
Jim Cramer in a recent program talked about the importance of The Dow Jones Industrial Average touching the 40,000 mark for the first time ever.
Hedge Fund Resource Center